Bette Caan to Survival Rate
This is a "connection" page, showing publications Bette Caan has written about Survival Rate.
Connection Strength
0.629
-
Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
Score: 0.131
-
Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1115-25.
Score: 0.094
-
Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Control. 2008 Dec; 19(10):1319-28.
Score: 0.072
-
Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. Cancer Epidemiol Biomarkers Prev. 2019 12; 28(12):2062-2069.
Score: 0.039
-
Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations. Int J Cancer. 2016 09 01; 139(5):1065-72.
Score: 0.031
-
Validation of self-reported comorbidity status of breast cancer patients with medical records: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Causes Control. 2016 Mar; 27(3):391-401.
Score: 0.030
-
History of Recreational Physical Activity and Survival After Breast Cancer: The California Breast Cancer Survivorship Consortium. Am J Epidemiol. 2015 Jun 15; 181(12):944-55.
Score: 0.029
-
An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer. 2015 Jul 15; 137(2):428-38.
Score: 0.028
-
Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):361-8.
Score: 0.028
-
The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control. 2013 Oct; 24(10):1821-36.
Score: 0.025
-
Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer. 2011 Jun 01; 128(11):2726-34.
Score: 0.021
-
Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol. 2010 Feb 20; 28(6):1005-10.
Score: 0.020
-
Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res Treat. 2010 Aug; 122(3):859-65.
Score: 0.020
-
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer. Int J Cancer. 2009 Dec 01; 125(11):2704-10.
Score: 0.020
-
The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
Score: 0.018
-
Plasma carotenoids and recurrence-free survival in women with a history of breast cancer. J Clin Oncol. 2005 Sep 20; 23(27):6631-8.
Score: 0.015
-
Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control. 1997 Mar; 8(2):146-58.
Score: 0.008